NewcelX Ltd.

Healthcare · Biotechnology · Switzerland

Last price 2.55 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.73M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep dis...